USE OF ANTI-L3T4 AND ANTI-Ia TREATMENTS FOR PROLONGATION OF XENOGENEIC ISLET TRANSPLANTS
- 1 August 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 46 (2) , 210-215
- https://doi.org/10.1097/00007890-198808000-00005
Abstract
An abstract is unavailable. This article is available as a PDF only.This publication has 25 references indexed in Scilit:
- Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.The Journal of Experimental Medicine, 1985
- Reversal of Experimental Allergic Encephalomyelitis with Monoclonal Antibody to a T-Cell Subset MarkerScience, 1985
- T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.The Journal of Immunology, 1984
- Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens.The Journal of Immunology, 1984
- PROLONGATION OF ISLET XENOGRAFT SURVIVAL BY IN VITRO CULTURE OF RAT MEGAISLETS IN 95% O21Transplantation, 1982
- Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants.Proceedings of the National Academy of Sciences, 1981
- Serological and biochemical characterization of rat (RT1) class II molecules with restricted mouse anti-Ia seraImmunogenetics, 1981
- Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.Proceedings of the National Academy of Sciences, 1980
- Prolongation of Islet Allograft Survival Following in Vitro Culture (24°C) and a Single Injection of ALSScience, 1979
- PROLONGED SURVIVAL OF XENOGRAFTS AFTER ORGAN-CULTURE1977